ChiCTR2600123376 版本V1.0 版本创建时间2026/04/26 17:02:52 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600123376 

最近更新日期:

Date of Last Refreshed on:

2026-04-26 17:02:26 

注册时间:

Date of Registration:

2026-04-26 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

未完成的课题:年轻肺癌父母对子女未来的长期担忧与预测

Public title:

Ongoing Research: Long-Term Worries About Children’s Future and Predictive Factors Among Young Lung Cancer Parents

注册题目简写:

English Acronym:

研究课题的正式科学名称:

中青年肺癌患者养育忧虑的纵向轨迹及预测因素研究

Scientific title:

Longitudinal Trajectory and Predictive Factors of Parenting Anxiety Among Young and Middle-Aged Lung Cancer Patients

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

荀细辉 

研究负责人:

荀细辉 

Applicant:

Xun Xihui 

Study leader:

Xun Xihui 

申请注册联系人电话:

Applicant telephone:

+86 13923739713

研究负责人电话:

Study leader's telephone:

+86 755 83366388

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

xunxihui@126.com

研究负责人电子邮件:

Study leader's E-mail:

xunxihui@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

深圳市福田区笋岗西路3002号

研究负责人通讯地址:

深圳市福田区华富街道笋岗西路3002号

Applicant address:

No. 3002, Sungang West Road, Futian District, Shenzhen City

Study leader's address:

3002 Sungang Road, Futian District, Shenzhen, Guangdong Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

深圳市第二人民医院

Applicant's institution:

The Second People's Hospital of Shenzhen City

研究负责人所在单位:

深圳市第二人民医院

Affiliation of the Leader:

Shenzhen Second People's Hospital

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2025-309-03PJ

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

深圳市第二人民医院临床科研伦理委员会

Name of the ethic committee:

Clinical Research Ethics Committee of Shenzhen Second People's Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2025-04-27 00:00:00

伦理委员会联系人:

杨鸿瑜

Contact Name of the ethic committee:

Yang Hongyu

伦理委员会联系地址:

深圳市福田区华富街道笋岗西路3002号

Contact Address of the ethic committee:

3002 Sungang Road, Futian District, Shenzhen, Guangdong Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 755 83464301

伦理委员会联系人邮箱:

Contact email of the ethic committee:

hyyoung95@163.com

研究实施负责(组长)单位:

深圳市第二人民医院

Primary sponsor:

Shenzhen Second People's Hospital

研究实施负责(组长)单位地址:

深圳市福田区华富街道笋岗西路3002号

Primary sponsor's address:

3002 Sungang Road, Futian District, Shenzhen, Guangdong Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东省

市(区县):

Country:

China

Province:

Guangdong

City:

单位(医院):

深圳市第二人民医院

具体地址:

深圳市福田区华富街道笋岗西路3002号

Institution
hospital:

Shenzhen Second People's Hospital

Address:

3002 Sungang Road, Futian District, Shenzhen, Guangdong Province

经费或物资来源:

深圳市第二人民医院内部科研基金

Source(s) of funding:

Internal Research Fund of The Second People's Hospital of Shenzhen

Target disease:

lung cancer (Young and Middle-Aged Patients with Minor Children)

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

(1)纵向调查中青年肺癌患者从初次确诊后、确诊后 1 个月 、确诊后3个月 、确诊后6个月不同时间点养育忧虑的变化水平,采用增长混合模型拟合患者不同类别的养育忧虑变化轨迹; (2)探讨影响中青年肺癌患者不同养育忧虑变化轨迹的预测指标。 (3)为制定针对性的心理干预措施提供科学依据,帮助患者及其家庭更好地应对养育挑战。  

Objectives of Study:

(1) Conduct a longitudinal survey on the changes in parenting anxiety levels among young and middle-aged lung cancer patients at different time points: immediately after initial diagnosis, 1 month after diagnosis, 3 months after diagnosis, and 6 months after diagnosis. Use a growth mixture model to fit the different types of parenting anxiety change trajectories in patients. (2) Explore the predictive indicators that affect the different parenting anxiety change trajectories of young and middle-aged lung cancer patients. (3) Provide a scientific basis for formulating targeted psychological intervention measures to help patients and their families better cope with parenting challenges.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.知情同意,自愿参与本调查; 2.经病理组织学确诊为肺癌; 3.年龄18~59岁; 4.目前正在抚养年龄<18岁的未成年子女; 5.意识清楚,能理解问卷内容。

Inclusion criteria

1. Voluntarily participate and sign informed consent; 2. Pathologically confirmed lung cancer; 3. Aged 18-59 years; 4. Currently raising children <18 years old; 5. Clear consciousness and able to understand questionnaires.

排除标准:

1.神志不清者、既往有精神疾病者; 2.患有其他严重疾病者。

Exclusion criteria:

1. Those with clouded consciousness or a history of mental illness; 2. Those suffering from other serious diseases;

研究实施时间:

Study execute time:

From 2025-01-01 00:00:00 To 2027-02-28 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-05-10 00:00:00 To 2026-02-28 00:00:00  

干预措施:

Interventions:

组别:

观察队列

样本量:

336

Group:

Observation Cohort

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东省 

市(区县):

 

Country:

China 

Province:

Guangdong 

City:

 

单位(医院):

深圳市第二人民医院 

单位级别:

三级甲等 

Institution
hospital:

Shenzhen Second People's Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

主要结局指标:养育忧虑水平变化

指标类型:

主要指标

Outcome:

Outcome: Changes in parenting anxiety levels

Type:

Primary indicator

测量时间点:

T1:初次确诊后;T2:确诊后1个月;T3:确诊后3个月;T4:确诊后6个月

测量方法:

采用 《中文版养育忧虑问卷(PCQ汉化版)》 进行测量。该问卷专为评估患儿父母的疾病相关担忧而设计,具有良好的信效度。其包含13个条目,采用5点Likert计分法(1=“无担忧”,5=“极其担忧”),总分为13-65分,得分越高代表养育忧虑水平越高。 评估程序: 在入组时(T0,基线)、诊断后或主要治疗后3个月(T1)、6个月(T2)、12个月(T3)共四个时间点,对患者进行纵向重复测量。 “

Measure time point of outcome:

T1: After initial diagnosis; T2: 1 month after diagnosis; T3: 3 months after diagnosis; T4: 6 months

Measure method:

The primary outcome, “change in parenting concern levels,” is measured using the Chinese Version of the Parenting Concerns Questionnaire (PCQ). This questionnaire is specifically designed to assess illness-related worries among parents of children with disease and has demonstrated good reliability and validity. It consists of 13 items rated on a 5-point Likert scale (1 = “Not worried at all,” 5 = “Extremely worried”), with a total score ranging from 13 to 65. Higher scores indicate higher levels

指标中文名:

养育胜任感

指标类型:

次要指标

Outcome:

Nurturing a sense of competence

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

焦虑抑郁

指标类型:

次要指标

Outcome:

anxiety and depression

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

社会支持

指标类型:

次要指标

Outcome:

social support

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

NA

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 59 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

限制共享:仅向符合学术研究目的、通过伦理审查的科研人员提供去标识化后的原始数据,不向公众公开原始数据以保护受试者隐私。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Restriction on sharing: De-identified raw data will only be provided to researchers who meet the purposes of academic research and have passed ethical review. Raw data will not be made public to protect the privacy of subjects.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

1. 数据采集:研究人员经统一培训后,采用标准化问卷调查方式采集数据。初次确诊后在院内当场发放问卷,指导受试者填写并当场回收,核对无遗漏后存档;确诊后1个月、3个月、6个月通过电话随访形式,逐条解释问卷内容并记录受试者回答,确保数据真实完整。 2. 数据管理:① 数据录入:问卷回收后,由2名研究人员独立核对问卷信息,双人双录入Excel软件,对录入不一致的数据核查原始问卷后修正;② 数据存储:录入后的数据导入IBM SPSS Statistics 26.0、N2Mplus及Mplus8.0软件用于统计分析,原始问卷及电子数据存储于加密计算机及医院专用科研数据存储设备,设置访问权限;③ 数据保密:所有数据均进行去标识化处理,受试者个人身份信息与研究数据分离存储,严格遵守保密规定,防止隐私泄露;④ 数据核查:邀请统计学专家对数据录入及分析方法进行评议,确保数据质量。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

1. Data collection: Trained researchers collect data via standardized questionnaires. After initial diagnosis, questionnaires are distributed and completed on-site in the hospital, with researchers providing guidance; completed questionnaires are retrieved immediately and checked for completeness before archiving. At 1 month, 3 months, and 6 months after diagnosis, follow-up data are collected via telephone interviews, where researchers explain questionnaire items one by one and record responses to ensure data authenticity and integrity. 2. Data management: ① Data entry: After questionnaire retrieval, two researchers independently verify the information and perform double data entry into Excel software. Inconsistencies are corrected by cross-checking with the original questionnaires; ② Data storage: Entered data are imported into IBM SPSS Statistics 26.0, N2Mplus, and Mplus8.0 for statistical analysis. Original questionnaires and electronic data are stored in encrypted computers and dedicated research data storage devices of the hospital with access permission controls; ③ Data confidentiality: All data are de-identified, and participants' personal information is stored separately from research data. Strict confidentiality regulations are followed to prevent privacy leakage; ④ Data verification: Statistical experts are invited to review the data entry and analysis methods to ensure data quality.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2026-04-26 17:02:26